118 related articles for article (PubMed ID: 33965622)
1. Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis.
Garg K; Kaur P; Bedi RK; Gupta S
Transfus Clin Biol; 2021 Aug; 28(3):239-245. PubMed ID: 33965622
[TBL] [Abstract][Full Text] [Related]
2. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors.
Lokhande T; Thomas S; Kumar G; Bajpai M
Indian J Hematol Blood Transfus; 2021 Apr; 37(2):295-301. PubMed ID: 33867737
[TBL] [Abstract][Full Text] [Related]
3. Hypocalcemic symptoms during plateletpheresis using the COBE Spectra: a comparison of oral combination of 600mg calcium+300mg magnesium+100IU vitamin D3 vs. a 1000mg calcium in symptomatic donors.
Palfi M; Martinsson L; Sundström K
Transfus Apher Sci; 2007 Jun; 36(3):291-5. PubMed ID: 17613274
[TBL] [Abstract][Full Text] [Related]
4. Calcium and magnesium levels during automated plateletpheresis in normal donors.
Das SS; Chaudhary R; Khetan D; Shukla JS; Agarwal P; Mishra RB
Transfus Med; 2005 Jun; 15(3):233-6. PubMed ID: 15943708
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of changes in clinically significant divalent serum cation levels during automated plateletpheresis in healthy donors in a tertiary care center in North India.
Solanki A; Agarwal P
Asian J Transfus Sci; 2015; 9(2):124-8. PubMed ID: 26420928
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study.
Pandey PK; Tiwari A; Agarwal N; Dara RC
Asian J Transfus Sci; 2020; 14(1):19-22. PubMed ID: 33162700
[TBL] [Abstract][Full Text] [Related]
7. Serial monitoring of ionised calcium levels in plateletpheresis donors: A study from tertiary care oncology centre in India.
Navkudkar A; Desai P; Rajadhyaksha S
Transfus Apher Sci; 2022 Jun; 61(3):103350. PubMed ID: 35012841
[TBL] [Abstract][Full Text] [Related]
8. Assessment of pre and post donation changes in hematological parameters and serum calcium and magnesium levels in plateletpheresis donors.
Syal N; Kukar N; Arora H; Kaur A; Handa A; Maharishi RN
J Family Med Prim Care; 2022 Apr; 11(4):1489-1492. PubMed ID: 35516708
[TBL] [Abstract][Full Text] [Related]
9. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects.
Bolan CD; Cecco SA; Yau YY; Wesley RA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2003 Oct; 43(10):1414-22. PubMed ID: 14507273
[TBL] [Abstract][Full Text] [Related]
10. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis.
Mercan D; Bastin G; Lambermont M; Dupont E
Transfusion; 1997 Apr; 37(4):418-22. PubMed ID: 9111280
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of citrate effects during plateletpheresis in normal donors.
Bolan CD; Greer SE; Cecco SA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2001 Sep; 41(9):1165-71. PubMed ID: 11552076
[TBL] [Abstract][Full Text] [Related]
12. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
13. Changes in protein-bound, complex-bound, and ionized calcium related to parathyroid hormone levels in healthy donors during plateletapheresis.
Toffaletti J
Transfusion; 1983; 23(6):471-5. PubMed ID: 6649022
[TBL] [Abstract][Full Text] [Related]
14. Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapheresis.
Toffaletti J; Nissenson R; Endres D; McGarry E; Mogollon G
J Clin Endocrinol Metab; 1985 May; 60(5):874-9. PubMed ID: 3980672
[TBL] [Abstract][Full Text] [Related]
15. Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms.
Bolan CD; Wesley RA; Yau YY; Cecco SA; Starling J; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2003 Oct; 43(10):1403-13. PubMed ID: 14507272
[TBL] [Abstract][Full Text] [Related]
16. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
[TBL] [Abstract][Full Text] [Related]
17. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
Morse EE; Hohnadel DC; Genco P; Katz AJ
Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
[TBL] [Abstract][Full Text] [Related]
18. The significance of evalution of haematocrit in plateletpheresis donors.
Mane VB; Jagtap PE; Nagane NS; Dhonde SP; Belwalkar GJ; Mane VP
J Clin Diagn Res; 2015 Apr; 9(4):BC06-7. PubMed ID: 26023547
[TBL] [Abstract][Full Text] [Related]
19. Serial analysis of hematological, biochemical, and immunological parameters alterations in regular healthy voluntary donors during plateletpheresis donation.
Hans R; Pahwa D; Paul P; Kaur J; Saikia B; Sharma RR; Marwaha N
Asian J Transfus Sci; 2023; 17(2):157-163. PubMed ID: 38274956
[TBL] [Abstract][Full Text] [Related]
20. A liquid calcium+vitamin D
Weinstein R; Haynes S; Zhao Y; Hickson E; Linden J; St Pierre P; Ducharme P; Sulmasy P; Graves M; Bailey JA; Welch L; Simard A; Vauthrin M; Greene M
J Clin Apher; 2018 Feb; 33(1):60-64. PubMed ID: 28653765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
